Emergence of antibodies as biomarkers in multiple sclerosis

By Berger Thomas   Reindl Markus  

Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. : 57-66

Future Medicine

Access to resources Recommend Favorite

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis

By Cottrell DA   Kremenchutzky M   Rice GPA   Hader W   Baskerville J   Ebers GC  

Brain, Vol. 122, Iss. 4, 1999-04 ,pp. : 641-647

Oxford University Press

Access to resources Recommend Favorite

Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-α-treated primary cultures of human microvascular endothelial cells: Implications for multiple sclerosis

By Avasarala Jagannadha   Konduru Sastry  

Journal of Molecular Neuroscience, Vol. 25, Iss. 2, 2005-06 ,pp. : 183-189

Humana Press, Inc

Access to resources Recommend Favorite

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

By Linker Ralf A.  

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2248-2263

Oxford University Press

Access to resources Recommend Favorite

Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis

By Longbrake Erin   Parks Becky   Cross Anne  

Current Neurology and Neuroscience Reports, Vol. 13, Iss. 11, 2013-11 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite